COMMUNIQUÉS West-GlobeNewswire

-
LifeLabs Supports Communities Impacted by Saskatchewan Wildfires with $15,000 Donation
10/06/2025 -
Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program
10/06/2025 -
Gelteq Expands U.S. Operations with Healthy Extracts Inc. as North American Fulfillment Partner
10/06/2025 -
Windtree Announces Transformational Agreement to Acquire Revenue Generating Environmental Services Business
10/06/2025 -
Hydrafacial Unveils New HydraFillic with Pep9™ Skin Booster For Fine Line & Wrinkles
10/06/2025 -
X4 Pharmaceuticals Granted Fast Track Designation for Mavorixafor for the Treatment of Chronic Neutropenia by U.S. FDA
10/06/2025 -
Arcutis Enrolls First Child in INTEGUMENT-INFANT Evaluating ZORYVE® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis
10/06/2025 -
Gain Therapeutics to Participate in Upcoming Investor Conferences
10/06/2025 -
CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization
10/06/2025 -
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
10/06/2025 -
NeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBS
10/06/2025 -
Vivex® Biologics, Inc. Appoints Industry Veteran Jon E. Block, Ph.D., as Chief Clinical Officer
10/06/2025 -
BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team
10/06/2025 -
Synergy CHC (NASDAQ: SNYR) Taps Former Coca-Cola Executive to Help Drive FOCUSfactor Energy Drink Global Expansion
10/06/2025 -
DeepView® System highlighted at the annual British Burn Association conference
10/06/2025 -
BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego
10/06/2025 -
Alignment Healthcare Founder and CEO John Kao Named to AHIP Board
10/06/2025 -
MBX Biosciences to Present at the American Diabetes Association 85th Scientific Sessions
10/06/2025 -
RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program
10/06/2025
Pages